Glucocerebrosidase-IN-1 (compound 11a) 是一种有效的选择性的GCase(葡糖脑苷脂酶)抑制剂，其IC50为 29.3 μM，Ki为 18.5 μM。由于GCase参与酶缺乏性病理疾病，Glucocerebrosidase-IN-1 可用于戈谢病 (GD) 和帕金森病 (PD) 的研究。

Glucocerebrosidase-IN-1 (compound 11a) is a potent and selective GCase (glucocerebrosidase) inhibitor, with an IC 50 of 29.3 μM and a K i of 18.5 μM. Due to GCase involvement in pathological disorders consequent to enzyme deficiency, Glucocerebrosidase-IN-1 can be used for the research of Gaucher disease (GD) and Parkinson’s disease (PD)[1].

Glucocerebrosidase-IN-1 (compound 11a) can enhance GCase activity 1.8-fold in fibroblasts bearing the homozygous L444P mutation [1].

2279945-76-3

C13H27NO3

245.36

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years